معرفی
Dr. Frank David is Professor of the Practice of Biotechnology in Tufts University's Department of Biology. He concurrently serves as Managing Director of Pharmagellan, a biotech R&D strategy consulting firm, and is affiliated with the Harvard-MIT Center for Regulatory Science.
Education:
- M.D., Columbia University Medical Center
- Ph.D., Columbia University Medical Center
His work focuses on biopharma strategy, clinical trial analysis, drug pricing economics, and R&D financial modeling. He is the author of industry handbooks on biotech forecasting and clinical trial analysis.
Professional Background: Previously held academic and administrative positions at UC Berkeley and completed residency at Brigham and Women's Hospital.
۰مقاله منتشرشده
